Sensex Closes 155 Points Higher; Realty & Telecom Stocks Outperform

Indian share markets ended the day on a positive note, though off their high points. At the closing bell, BSE Sensex ended up by 155 points, while, NSE Nifty ended up by 49 points.

Barring metal stockscapital goods stocks and healthcare stocks, all sectoral indices ended in green with realty stocks and telecom stocks witnessing maximum buying interest.

Globally, Asian stock markets finished broadly higher today with shares in Japan leading the region. The Nikkei 225 is up 2.4% while Hong Kong's Hang Seng is up 0.8% and China's Shanghai Composite is up 0.7%. European markets are lower today with shares in France off the most. The CAC 40 is down 0.2% while London's FTSE 100 is off 0.2% and Germany's DAX is lower by 0.1%.

Pharma stocks ended the day on a mixed note with Ajanta Pharma & Aarti Drugs leading the pack of gainers. As per an article in a leading financial daily, Lupin has received approval from the United States Food and Drug Administration (USFDA) for Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg & 120 mg.

It has received approval to market a generic version of Sunovion Pharmaceuticals, Inc's Latuda Tablets.

Lupin's Lurasidone Hydrochloride Tablets is indicated for the treatment of adult patients with schizophrenia, monotherapy treatment of adult patients with major depressive episode associated with bipolar I disorder.

Reportedly, Latuda tablets had annual sales of approximately US$3217.3 million in the US (IQVIA MAT September 2018).

To know more about the company, you can access to Lupin's Q2FY19 result analysis and Lupin's 2017-18 Annual Report Analysis on our website.

Lupin share price ended the day down by 1.1%.

Moving on to the news from finance sector. As per an article in a leading financial daily, IL&FS Transportation Networks, a group company of the troubled IL&FS group, defaulted on dividend payment of Rs 71.2 million due on redemption of cumulative non-convertible redeemable preference shares.

1 2 3
View single page >> |

Disclosure: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. ...

more
How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.